489 related articles for article (PubMed ID: 19827655)
1. [Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment].
Vorob'eva NM; Panchenko EP; Kirienko AI; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Andriiashkin VV; Leont'ev SG
Ter Arkh; 2009; 81(9):57-61. PubMed ID: 19827655
[TBL] [Abstract][Full Text] [Related]
2. [Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis].
Vorob'eva NM; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Kirienko AI; Panchenko EP
Ter Arkh; 2008; 80(7):50-4. PubMed ID: 18763596
[TBL] [Abstract][Full Text] [Related]
3. [Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins].
Vorob'eva NM; Panchenko EP; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Khasanova ZB; Postnov AIu; Kirienko AI
Ter Arkh; 2011; 83(8):33-7. PubMed ID: 21961329
[TBL] [Abstract][Full Text] [Related]
4. [Improving recanalization of deep veins and the "outcomes" of venous thromboembolic complications in prolonged therapy with enoxaparin].
Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Kirienko AI
Angiol Sosud Khir; 2010; 17(1):87-94. PubMed ID: 21780625
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.
Narin C; Reyhanoglu H; Tülek B; Onoglu R; Ege E; Sarigül A; Yeniterzi M; Durmaz I
Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442
[TBL] [Abstract][Full Text] [Related]
6. [Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications].
Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Khasanova ZB; Postnov AIu; Kirienko AI
Ter Arkh; 2011; 83(12):43-8. PubMed ID: 22416444
[TBL] [Abstract][Full Text] [Related]
7. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
[TBL] [Abstract][Full Text] [Related]
9. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
[TBL] [Abstract][Full Text] [Related]
10. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
11. High doses of warfarin are more beneficial than its low doses in patients with deep vein thrombosis.
Farahmand S; Saeedi M; Seyed Javadi HH; Khashayar P
Am J Emerg Med; 2011 Nov; 29(9):1222-6. PubMed ID: 21035980
[TBL] [Abstract][Full Text] [Related]
12. Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group.
Gazzaniga GM; Angelini G; Pastorino G; Santoro E; Lucchini M; Dal Prà ML
Int Surg; 1993; 78(3):271-5. PubMed ID: 8276557
[TBL] [Abstract][Full Text] [Related]
13. Out-patient treatment of acute deep vein thrombosis.
Mattiasson I; Berntorp E; Bornhov S; Lagerstedt C; Lethagen S; Persson J; Timberg I; Torstensson I
Int Angiol; 1998 Sep; 17(3):146-50. PubMed ID: 9821026
[TBL] [Abstract][Full Text] [Related]
14. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
Heidenreich C; Hohmann V; Bramlage P
Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
[TBL] [Abstract][Full Text] [Related]
15. [The study of Chinese optimal anticoagulant range of warfarin for venous thromboembolism].
Yang P; Wu QH; Luo XY; Kou L; Chen Z; Zhang YY; Zhou H
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1762-5. PubMed ID: 19862981
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory therapy of patients with free-floating proximal deep vein thrombosis is safe.
Patel RK; Ramasamy K; Goss D; Deane C; Bonner L; Arya R
Thromb Haemost; 2005 Dec; 94(6):1343-4. PubMed ID: 16411421
[No Abstract] [Full Text] [Related]
17. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery.
Scholten DJ; Hoedema RM; Scholten SE
Obes Surg; 2002 Feb; 12(1):19-24. PubMed ID: 11868291
[TBL] [Abstract][Full Text] [Related]
18. Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.
González-Fajardo JA; Martin-Pedrosa M; Castrodeza J; Tamames S; Vaquero-Puerta C
J Vasc Surg; 2008 Oct; 48(4):953-9. PubMed ID: 18639417
[TBL] [Abstract][Full Text] [Related]
19. Frequency of bleeding following invasive dental procedures in patients on low-molecular-weight heparin therapy.
Hong CH; Napeñas JJ; Brennan MT; Furney SL; Lockhart PB
J Oral Maxillofac Surg; 2010 May; 68(5):975-9. PubMed ID: 20144498
[TBL] [Abstract][Full Text] [Related]
20. Deep vein thrombosis and anticoagulant therapy.
Sullano MA; Ortiz EJ
Nurs Clin North Am; 2001 Dec; 36(4):645-63, v. PubMed ID: 11726345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
